CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
NASDAQ:CCRN - Nasdaq - US2274831047 - Common Stock - Currency: USD
CCRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for CCRN as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, CCRN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
In the past year CCRN had a positive cash flow from operations.
In multiple years CCRN reported negative net income over the last 5 years.
CCRN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCRN has a Return On Assets of -2.47%. This is comparable to the rest of the industry: CCRN outperforms 41.18% of its industry peers.
CCRN has a Return On Equity (-3.47%) which is comparable to the rest of the industry.
CCRN has a Return On Invested Capital of 0.19%. This is in the lower half of the industry: CCRN underperforms 61.76% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCRN is significantly above the industry average of 9.13%.
The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.19%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -3.47% | ||
| ROIC | 0.19% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
CCRN has a worse Operating Margin (0.09%) than 62.75% of its industry peers.
In the last couple of years the Operating Margin of CCRN has declined.
CCRN has a Gross Margin (20.41%) which is in line with its industry peers.
CCRN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 20.41% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCRN has less shares outstanding
The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CCRN has an Altman-Z score of 4.81. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.81, CCRN belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.81 |
ROIC/WACC0.02
WACC8.89%
2.3 Liquidity
A Current Ratio of 2.78 indicates that CCRN has no problem at all paying its short term obligations.
CCRN has a Current ratio of 2.78. This is amongst the best in the industry. CCRN outperforms 85.29% of its industry peers.
CCRN has a Quick Ratio of 2.78. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.78, CCRN belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.78 | ||
| Quick Ratio | 2.78 |
3. Growth
3.1 Past
The earnings per share for CCRN have decreased strongly by -79.64% in the last year.
Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
CCRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.46%.
CCRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.33% yearly.
EPS 1Y (TTM)-79.64%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-86.21%
Revenue 1Y (TTM)-33.46%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-25.14%
3.2 Future
The Earnings Per Share is expected to grow by 11.41% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.51% on average over the next years.
EPS Next Y-14.19%
EPS Next 2Y10.43%
EPS Next 3Y11.41%
EPS Next 5YN/A
Revenue Next Year-7.39%
Revenue Next 2Y-1.62%
Revenue Next 3Y0.51%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 30.24, CCRN can be considered very expensive at the moment.
CCRN's Price/Earnings is on the same level as the industry average.
CCRN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.22.
The Price/Forward Earnings ratio is 35.25, which means the current valuation is very expensive for CCRN.
CCRN's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (20.86), we can say CCRN is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.24 | ||
| Fwd PE | 35.25 |
4.2 Price Multiples
CCRN's Enterprise Value to EBITDA ratio is in line with the industry average.
97.06% of the companies in the same industry are more expensive than CCRN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.01 | ||
| EV/EBITDA | 18.62 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.23
EPS Next 2Y10.43%
EPS Next 3Y11.41%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
13.61
+0.08 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.1%
Inst Owner Change0.06%
Ins Owners5.71%
Ins Owner Change0.18%
Market Cap446.27M
Analysts52.31
Price Target18.98 (39.46%)
Short Float %10.42%
Short Ratio7.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.94%
Min EPS beat(2)-66.11%
Max EPS beat(2)22.23%
EPS beat(4)2
Avg EPS beat(4)-15.28%
Min EPS beat(4)-66.11%
Max EPS beat(4)22.23%
EPS beat(8)5
Avg EPS beat(8)-5.24%
EPS beat(12)9
Avg EPS beat(12)1.38%
EPS beat(16)13
Avg EPS beat(16)11.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)-0.41%
Revenue beat(8)2
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)0.51%
Revenue beat(16)9
Avg Revenue beat(16)2.74%
PT rev (1m)6.6%
PT rev (3m)6.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.42%
EPS NY rev (1m)-5.69%
EPS NY rev (3m)-33.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.24 | ||
| Fwd PE | 35.25 | ||
| P/S | 0.33 | ||
| P/FCF | 4.01 | ||
| P/OCF | 3.72 | ||
| P/B | 1.07 | ||
| P/tB | 1.85 | ||
| EV/EBITDA | 18.62 |
EPS(TTM)0.45
EY3.31%
EPS(NY)0.39
Fwd EY2.84%
FCF(TTM)3.4
FCFY24.96%
OCF(TTM)3.66
OCFY26.92%
SpS40.99
BVpS12.78
TBVpS7.37
PEG (NY)N/A
PEG (5Y)1.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -3.47% | ||
| ROCE | 0.27% | ||
| ROIC | 0.19% | ||
| ROICexc | 0.23% | ||
| ROICexgc | 0.42% | ||
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 20.41% | ||
| FCFM | 8.29% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexcg growth 3Y-75.41%
ROICexcg growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score4
Asset Turnover2.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 47.88% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 0.91 | ||
| Cash Conversion | 617.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.78 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 4.81 |
F-Score4
WACC8.89%
ROIC/WACC0.02
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.64%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-86.21%
EPS Next Y-14.19%
EPS Next 2Y10.43%
EPS Next 3Y11.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-33.46%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-25.14%
Revenue Next Year-7.39%
Revenue Next 2Y-1.62%
Revenue Next 3Y0.51%
Revenue Next 5YN/A
EBIT growth 1Y-98.94%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year791.51%
EBIT Next 3Y125.79%
EBIT Next 5YN/A
FCF growth 1Y-52.5%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-51.66%
OCF growth 3YN/A
OCF growth 5Y85.29%